We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Activity, Adiposity, and Appetite in Adolescents 2 (AAAA2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04028921
Recruitment Status : Recruiting
First Posted : July 23, 2019
Last Update Posted : June 10, 2022
Sponsor:
Information provided by (Responsible Party):
Robin Shook, Children's Mercy Hospital Kansas City

Brief Summary:
Our goal is to examine linkages between physical activity, appetite control, and energy metabolism in adolescents. The investigators will assess metabolic function and appetite control in male and female adolescents stratified by bodyweight and physical activity using across-sectional study design.

Condition or disease Intervention/treatment
Obesity Metabolic Disease Insulin Sensitivity Other: No intervention

Detailed Description:
Childhood obesity is the most serious public health problem of the 21st century, given the prevalence, global reach, and widespread health, economic, and social consequences. While weight gain at the most basic level is due to a chronic energy surplus, there are a host of influences that act on the energy balance system that remain largely unknown. Thus, there is a critical need to identify previously unexamined factors that may influence the energy balance system in order to develop effective interventions for prevention and treatment. Our long-term goal is to quantify the dynamic relationships between various physiological and psychological components of the energy balance system. Our short-term goal is to examine linkages between physical activity, appetite control, and energy metabolism in adolescents. The status quo as it relates to appetite control is that body weight status and related peripheral signals are a key regulator of energy intake. In contrast to body weight playing a primary role in energy regulation, our working hypothesis is that high levels of regular moderate-to-vigorous physical activity (MVPA) result in a metabolic phenotype consisting of enhanced metabolic function and proper regulation of appetite, which prevents the development of obesity. The investigators have reported that adults with low levels of MVPA have dysregulated appetite control, evidenced by higher levels of energy intake and elevated levels of dietary disinhibition. Additionally, the investigators have observed that rats with low fitness possess dysregulated control of appetite and reduced hepatic fat oxidation compared to rats with high fitness. Based on these findings in adults and rodents, in addition to supportive work by others, the investigators hypothesize that low levels of MVPA create a metabolic phenotype, leading to dysregulated appetite control which predisposes individuals to weight gain. To test this hypothesis the investigators will perform a study focused on the links between physical activity and appetite. The investigators will assess metabolic function and appetite control in male and female adolescents stratified by bodyweight (normal vs overweight/obese) and physical activity (sedentary vs. active) using a 2 x 2 cross-sectional study design (N=44). The specific aim of the proposed study is: 1) To examine the association between physical activity and appetite control in adolescents, with metabolic function serving as a mediator. At the completion of the study, it is our expectation that the investigators will have described the independent effects of physical activity and body weight on energy metabolism and appetite in adolescents. This study will have a significant positive impact on the understanding of energy balance in adolescents, and will inform public health interventions that specifically target mechanisms associated with weight gain in youth.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 44 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Activity, Adiposity, and Appetite in Adolescents 2
Actual Study Start Date : January 3, 2022
Estimated Primary Completion Date : September 1, 2023
Estimated Study Completion Date : September 1, 2023

Group/Cohort Intervention/treatment
Normal weight, active
Male and female adolescents (age 14-17 years), BMI percentile >=5th to <75th for age/sex, >=60 min/day of moderate/vigorous physical activity.
Other: No intervention
This is a cross-sectional study; no intervention

Normal weight, sedentary
Male and female adolescents (age 14-17 years), BMI percentile >=5th to <75th for age/sex, <60 min/day of moderate/vigorous physical activity.
Other: No intervention
This is a cross-sectional study; no intervention

Overweight/obese, active
Male and female adolescents (age 14-17 years), BMI percentile >=85th to <99th for age/sex, >=60 min/day of moderate/vigorous physical activity.
Other: No intervention
This is a cross-sectional study; no intervention

Overweight/obese, sedentary
Male and female adolescents (age 14-17 years), BMI percentile >=85th to <99th for age/sex, <60 min/day of moderate/vigorous physical activity.
Other: No intervention
This is a cross-sectional study; no intervention




Primary Outcome Measures :
  1. Appetite- subjective [ Time Frame: Baseline ]
    The investigators will measure subjective appetite ratings using visual analog scales related to hunger following a fixed-calorie meal.

  2. Appetite- objective [ Time Frame: Baseline ]
    The investigators will measure objective appetite responses using plasma ghrelin following a fixed-calorie meal.

  3. Appetite- adjusted [ Time Frame: Baseline ]
    The investigators will measure objective and subjective appetite responses as described above adjusted by insulin sensitivity (glucose infusion rate, mg/kg/min) as assessed in the euglycemic hyperinsulinemic clamp technique.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Healthy males and females.
Criteria

Inclusion Criteria:

  • Tanner Stage III-V
  • Weight-stable (± 10%) within the previous 3 months
  • Non-smoking
  • Not currently involved in any other research study

Exclusion Criteria:

  • Restrained eater (>13) on the restraint section of the three-factor eating questionnaire; Current/past diagnosis of an eating disorder
  • Past pregnancy
  • Self-reported medical conditions (diabetes, Crohn's disease, etc.) that may affect adherence to the protocol or exercising safely or alter metabolism
  • Medications known to affect exercise performance or metabolism (e.g. thyroid medication, beta-blockers, or stimulants)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04028921


Contacts
Layout table for location contacts
Contact: Robin P Shook, PhD 2144488366 rpshook@cmh.edu
Contact: Paige Posson, MS, RD 816-234-9230 pmposson@cmh.edu

Locations
Layout table for location information
United States, Missouri
Children's Mercy Kansas City Recruiting
Kansas City, Missouri, United States, 64108
Contact: Robin Shook, PhD         
Sponsors and Collaborators
Children's Mercy Hospital Kansas City
Layout table for additonal information
Responsible Party: Robin Shook, Associate Professor, Children's Mercy Hospital Kansas City
ClinicalTrials.gov Identifier: NCT04028921    
Other Study ID Numbers: STUDY00001808
First Posted: July 23, 2019    Key Record Dates
Last Update Posted: June 10, 2022
Last Verified: June 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Aggregated results will be shared

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Insulin Resistance
Metabolic Diseases
Hyperinsulinism
Glucose Metabolism Disorders